Skip to main content

Table 3 The two patients who developed severe hemorrhage on relugolix

From: Characteristics of submucosal leiomyomas that could cause severe hemorrhage with relugolix: an observational study

 

Age (years)

Parity

BMI (kg/m2)

Hb (g/dL) (pre-treatment)

Hb (g/dL) (post-treatment)

Leiomyoma diameter (mm) (pre-treatment)

Leiomyoma diameter (mm) (post-treatment)

FIGO type of submucosal leiomyoma

Hemorrhage occurrence from start of relugolix (days)

Intervention

Patient 1

46

1

18.0

9.9

7.8

42

33

0

27

Transfusions, Emergent vaginal myomectomy

Patient 2

50

2

26.2

10.4

7.3

61

61

0

5

Transfusions, Emergent vaginal myomectomy

  1. BMI Body mass index, FIGO The international federation of gynecology and obstetrics, Hb Hemoglobin